CytoTronics is commercializing technology emerging from the Harvard University labs to bring unique insights to drug discovery. Our technology combines wet chemistry with novel semiconductors for in-vitro assays and bioinformatics never before available.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Massachusetts
Company HQ Country:
United States
Year Founded:
2021
Main Therapeutic Focus:
Platform for Therapeutics
Lead Product in Development:
Service-to-partnership products spanning Toxicology, Phenotypic Screening, Epithelial Diseases
Development Phase of Primary Product:
Discovery
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
